Evidence map›Paper›PMID 20194752›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.

Harriet C T Groom, Melvyn W Yap, Rui Pedro Galão, Stuart J D Neil, Kate N Bishop

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
8.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 98 citations in OpenAlex.

  1. Journal of virology · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Harriet C T GroomDivision of Virology, MRC National Institute for Medical Research, London NW7 1AA, United Kingdom.
Melvyn W Yap
Rui Pedro Galão
Stuart J D Neil
Kate N Bishop
Guy's Hospital · GBInfectious Disease Consultants · USKing's College London · GB

Funding

Medical Research Council MC_U117512710Medical Research Council MC_U117592729Wellcome Trust
6 · The paper itself

Abstract

Xenotropic murine leukemia virus-related virus (XMRV) is a recently discovered gammaretrovirus that has been linked to prostate cancer and chronic fatigue syndrome. This virus is therefore an important potential human pathogen and, as such, it is essential to understand its host cell tropism. Intriguingly, infectious virus has been recovered from patient-derived peripheral blood mononuclear cells. These cells express several antiviral restriction factors that are capable of inhibiting the replication of a wide range of retroviruses, including other gamma retroviruses. This raises the possibility that, similar to HIV, XMRV may have acquired resistance to restriction. We therefore investigated the susceptibility of XMRV to a panel of different restriction factors. We found that both human APOBEC3 and tetherin proteins are able to block XMRV replication. Expression of human TRIM5alpha, however, had no effect on viral infectivity. There was no evidence that XMRV expressed countermeasures to overcome restriction. In addition, the virus was inhibited by factors from nonhuman species, including mouse Apobec3, tetherin, and Fv1 proteins. These results have important implications for predicting the natural target cells for XMRV replication, for relating infection to viral pathogenicity and pathology, and for the design of model systems with which to study XMRV-related diseases.

Indexed as

AnimalsAntigens, CDAntiviral AgentsAntiviral Restriction FactorsAPOBEC DeaminasesBone Marrow Stromal Antigen 2Carrier ProteinsCell LineClone CellsCytidine DeaminaseCytosine DeaminaseGPI-Linked ProteinsHumansLeukemia Virus, MurineMembrane GlycoproteinsMiceAntigens, CDAntiviral AgentsAntiviral Restriction FactorsApobec3 protein, mouseAPOBEC3 proteins, humanAPOBEC DeaminasesBone Marrow Stromal Antigen 2BST2 protein, humanCarrier ProteinsCytidine DeaminaseCytosine DeaminaseGPI-Linked ProteinsMembrane GlycoproteinsTRIM5 protein, humanTripartite Motif ProteinsUbiquitin-Protein Ligases

Identifiers

PMID20194752
PMCPMC2841911
OpenAlexW2089144246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.